LINAGENTA TAB is a specialized oral antidiabetic medication formulated with 5 mg Linagliptin, targeting effective glycemic management for adults with Type 2 Diabetes Mellitus. Designed for once-daily administration, this advanced formulation selectively inhibits the Dipeptidyl Peptidase-4 (DPP-4) enzyme, thereby enhancing incretin hormone levels that regulate insulin release and suppress glucagon post-meal. This glucose-dependent mechanism minimizes risks of hypoglycemia and is weight-neutral, making it an ideal therapeutic choice for patients sensitive to weight fluctuation or hypoglycemic episodes. LINAGENTA TAB offers flexible treatment options as monotherapy or in combination with other anti-diabetic agents such as Metformin, Sulfonylureas, SGLT2 inhibitors, or Insulin. Its efficacy extends to patients with mild to moderate renal impairment without the need for dose adjustment, broadening its suitability across diverse clinical scenarios. Manufactured by BLUEPILL EXPRESS under the Dr Precision label, LINAGENTA TAB conforms to stringent WHO-GMP and ISO quality standards, ensuring superior formulation stability, bioavailability, and an extended shelf-life. The product supports hospital, retail, and institutional supply chains with flexible packaging and private labeling options, reinforcing its accessibility and adherence to global regulatory compliance. BLUEPILL EXPRESS’ capability in international tenders and governmental procurement further solidifies LINAGENTA TAB’s reliability as a trusted antidiabetic solution in the global pharmaceutical market.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Linagliptin 5 mg per tablet |
| Mechanism of Action | Selective Dipeptidyl Peptidase-4 (DPP-4) inhibitor |
| Dosage Form | Oral Tablets |
| Dosing Frequency | Once daily |
| Therapeutic Use | Management of Type 2 Diabetes Mellitus |
| Safety Profile | Low risk of hypoglycemia and weight neutral |
| Renal Impairment | No dose adjustment needed for mild to moderate renal impairment |
| Combination Therapy | Compatible with Metformin, Sulfonylureas, SGLT2 inhibitors, and Insulin |
| Manufacturer | BLUEPILL EXPRESS under Dr Precision label |
| Quality Standards | WHO-GMP, ISO certified, compliant with international regulations |
| Packaging | Flexible packaging with moisture protection for extended shelf life |
| Market Availability | Available for private labeling, third-party manufacturing, and global distribution |
| Attributes | Description |
|---|---|
| Active Substance | Linagliptin |
| Strength | 5 mg |
| Tablet Weight | Standardized for optimal bioavailability |
| Pharmacological Class | Oral Antidiabetic - DPP-4 Inhibitor |
| Shelf Life | Typically 24 months (subject to packaging and storage) |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Regulatory Compliance | Manufactured per WHO-GMP, ISO standards, suitable for regulated markets |
| Packaging Formats | Blister packs, bottle packaging with moisture barrier |
| Pharmacokinetics | Not requiring dose adjustments in renal impairment |
| Labeling Options | Available for private label and third party manufacturing |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
No, LINAGENTA TAB does not require dose adjustments for patients with mild to moderate renal impairment, making it a safe option for a broader diabetic population.
Yes, LINAGENTA TAB is compatible with combination therapy including Metformin, Sulfonylureas, SGLT2 inhibitors, and Insulin depending on the patient's glycemic profile.
Its glucose-dependent mechanism of inhibiting DPP-4 increases incretin hormones which regulate insulin secretion only when blood glucose is elevated, thereby minimizing the risk of hypoglycemia.
Yes, LINAGENTA TAB is weight neutral, which helps prevent weight gain common with some antidiabetic agents, improving patient adherence and long-term metabolic outcomes.
The product is manufactured under WHO-GMP and ISO certifications following stringent quality controls to ensure compliance with global regulatory requirements.
Country Of Origin: India
LINAGENTA TAB is an advanced oral antidiabetic medication containing Linagliptin, designed to effectively manage blood glucose levels in adults with Type 2 Diabetes Mellitus. Manufactured by BLUEPILL EXPRESS, it offers once-daily convenience and DPP-4 inhibition to support glycemic control without causing weight gain or significant hypoglycemia.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
LINAGENTA TAB is a cutting-edge pharmaceutical formulation developed for the management of Type 2 Diabetes Mellitus (T2DM). The active ingredient, Linagliptin, is a selective Dipeptidyl Peptidase-4 (DPP-4) inhibitor, a class of medications that enhances the body’s natural ability to lower elevated blood glucose levels by increasing incretin hormones. These hormones regulate insulin release after meals and suppress glucagon secretion, thereby reducing blood sugar levels in a glucose-dependent manner.
This mode of action makes LINAGENTA TAB highly effective and safe, as it carries a minimal risk of hypoglycemia compared to many traditional antidiabetic agents. It is particularly suitable for patients who are overweight or concerned about weight gain, as Linagliptin is weight-neutral. The once-daily oral dosage also improves patient adherence and simplifies treatment regimens.
LINAGENTA TAB can be used as a monotherapy or in combination with other antidiabetic agents such as Metformin, Sulfonylureas, SGLT2 inhibitors, or Insulin, depending on the patient’s glycemic profile and therapeutic needs. It is especially beneficial for patients with mild to moderate renal impairment, as Linagliptin does not require dose adjustment based on kidney function, making it a safe choice for long-term glycemic control in a broader patient population.
Each tablet of LINAGENTA contains a standardized dose of Linagliptin 5 mg, formulated for optimal bioavailability and stability. It is manufactured by BLUEPILL EXPRESS, a global pharmaceutical company with a reputation for high-quality formulations, robust quality control, and compliance with WHO-GMP, ISO, and regulatory certifications required for export to semi-regulated and regulated markets worldwide.
BLUEPILL EXPRESS employs the latest manufacturing technologies and adheres to stringent international standards to ensure every batch of LINAGENTA TAB delivers consistent therapeutic outcomes. The tablets are packaged with care to preserve potency, prevent moisture degradation, and offer extended shelf life for both hospital and retail supply chains.
The product is available in flexible packaging formats and can be supplied under private labeling or third-party manufacturing partnerships. With a global footprint and experience in handling international tenders, government supplies, institutional orders, and distributor networks, BLUEPILL EXPRESS ensures timely delivery, competitive pricing, and full technical documentation for LINAGENTA TAB.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
